Syndax Pharmaceuticals Inc (143) | Business Operations (11)
Browse by Subcategory
Recent Contracts
-
Sales Agreement, dated May 26, 2023
(Filed With SEC on May 26, 2023)
-
MUTUAL RELEASE AND SETTLEMENT AGREEMENT
(Filed With SEC on August 8, 2022)
-
Collaboration and License Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021
(Filed With SEC on November 15, 2021)
-
AMENDMENT NO. 1 TO CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (FOR NON-SMALL CELL LUNG CANCER STUDY WITH EXPANSION COHORTS INNON-SMALL CELL LUNG CANCER, MELANOMA, AND...
(Filed With SEC on August 10, 2017)
-
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT
(Filed With SEC on January 11, 2016)
-
INDEMNIFICATION AGREEMENT
(Filed With SEC on January 4, 2016)
-
CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (FOR NON-SMALL CELL LUNG CANCER STUDY WITH EXPANSION COHORTS IN NON-SMALL CELL LUNG CANCER AND MELANOMA)
(Filed With SEC on January 4, 2016)
-
COMBINATION STUDY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND SYNDAX PHARMACEUTICALS, INC. TABLE OF CONTENTS
(Filed With SEC on January 4, 2016)
-
TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing Section 5 U.S. Government Rights Section...
(Filed With SEC on May 16, 2014)
-
INDEMNIFICATION AGREEMENT
(Filed With SEC on March 27, 2014)
-
TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing Section 5 U.S. Government Rights Section...
(Filed With SEC on March 27, 2014)